{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:23:37Z","timestamp":1768479817316,"version":"3.49.0"},"reference-count":17,"publisher":"Centers for Disease Control and Prevention (CDC)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Emerg. Infect. Dis."],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.3201\/eid2906.230130","type":"journal-article","created":{"date-parts":[[2023,5,16]],"date-time":"2023-05-16T18:12:03Z","timestamp":1684260723000},"source":"Crossref","is-referenced-by-count":15,"title":["SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022"],"prefix":"10.3201","volume":"29","author":[{"given":"Lauren E.","family":"Bloomfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sera","family":"Ngeh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gemma","family":"Cadby","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kate","family":"Hutcheon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul V.","family":"Effler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1822","reference":[{"key":"key-10.3201\/eid2906.230130-202305021908-R1","unstructured":"Australian Government. COVID-19 vaccine roll-out: 01 February 2022 [cited 2023 Jan 30]. https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2022\/02\/covid-19-vaccine-rollout-update-1-february-2022.pdf"},{"key":"key-10.3201\/eid2906.230130-202305021908-R2","doi-asserted-by":"publisher","first-page":"5","DOI":"10.23889\/ijpds.v5i4.1730","article-title":"Using data linkage to monitor COVID-19 vaccination: development of a vaccination linked data repository.","volume":"5","author":"Eitelhuber","year":"2022","journal-title":"Int J Popul Data Sci"},{"key":"key-10.3201\/eid2906.230130-202305021908-R3","unstructured":"Government of Western Australia Department of Health. Hospital morbidity data collection: data specifications [cited 2023 Jan 30]. https:\/\/www.health.wa.gov.au\/-\/media\/Corp\/Policy-Frameworks\/Information-Management\/Patient%20Activity%20Data\/Supporting\/Hospital-Morbidity-Data-Collection-Data-Specifications-2022.pdf"},{"key":"key-10.3201\/eid2906.230130-202305021908-R4","doi-asserted-by":"publisher","first-page":"6288","DOI":"10.1016\/j.vaccine.2022.09.029","article-title":"Relative effectiveness of COVID-19 vaccination with 3 compared to 2 doses against SARS-CoV-2 B.1.1.529 (Omicron) among an Australian population with low prior rates of SARS-CoV-2 infection.","volume":"40","author":"Liu","year":"2022","journal-title":"Vaccine"},{"key":"key-10.3201\/eid2906.230130-202305021908-R5","unstructured":"Australian Bureau of Statistics. 2033.0.55.001\u2014Census of Population and Housing: Socio-Economic Indexes for Areas (SEIFA), Australia, 2016 [cited 2023 Jan 30]. https:\/\/www.abs.gov.au\/AUSSTATS\/abs@.nsf\/DetailsPage\/2033.0.55.0012016?OpenDocument"},{"key":"key-10.3201\/eid2906.230130-202305021908-R6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.18637\/jss.v042.i08","article-title":"MatchIt: nonparametric preprocessing for parametric causal inference.","volume":"42","author":"Ho","year":"2011","journal-title":"J Stat Softw"},{"key":"key-10.3201\/eid2906.230130-202305021908-R7","unstructured":"Government NSW. COVID-19 cases data [cited 2023 Jan 30]. https:\/\/data.nsw.gov.au\/nsw-covid-19-data\/cases"},{"key":"key-10.3201\/eid2906.230130-202305021908-R8","doi-asserted-by":"publisher","first-page":"e2137257","DOI":"10.1001\/jamanetworkopen.2021.37257","article-title":"Global percentage of asymptomatic SARS-CoV-2 infections among the tested population and individuals with confirmed COVID-19 diagnosis: a systematic review and meta-analysis.","volume":"4","author":"Ma","year":"2021","journal-title":"JAMA Netw Open"},{"key":"key-10.3201\/eid2906.230130-202305021908-R9","unstructured":"Australian Government. COVID-19 vaccine roll-out: 01 February 2022 [cited 2023 Jan 30]. https:\/\/www.health.gov.au\/sites\/default\/files\/documents\/2022\/02\/covid-19-vaccine-rollout-update-1-february-2022.pdf"},{"key":"key-10.3201\/eid2906.230130-202305021908-R10","doi-asserted-by":"publisher","first-page":"1532","DOI":"10.1056\/NEJMoa2119451","article-title":"Covid-19 vaccine effectiveness against the Omicron (B.1.1.529) variant.","volume":"386","author":"Andrews","year":"2022","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2906.230130-202305021908-R11","doi-asserted-by":"publisher","first-page":"e83","DOI":"10.1056\/NEJMoa2114114","article-title":"Waning of BNT162b2 vaccine protection against SARS-CoV-2 infection in Qatar.","volume":"385","author":"Chemaitelly","year":"2021","journal-title":"N Engl J Med"},{"key":"key-10.3201\/eid2906.230130-202305021908-R12","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/S1473-3099(22)00309-7","article-title":"COVID-19 vaccine effectiveness against the omicron (BA.2) variant in England.","volume":"22","author":"Kirsebom","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"key-10.3201\/eid2906.230130-202305021908-R13","doi-asserted-by":"publisher","first-page":"5699","DOI":"10.1016\/j.cell.2021.10.011","article-title":"Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine.","volume":"184","author":"Payne","year":"2021","journal-title":"Cell"},{"key":"key-10.3201\/eid2906.230130-202305021908-R14","doi-asserted-by":"publisher","first-page":"1530","DOI":"10.1038\/s41591-021-01464-w","article-title":"Immunogenicity and reactogenicity of heterologous ChAdOx1 nCoV-19\/mRNA vaccination.","volume":"27","author":"Schmidt","year":"2021","journal-title":"Nat Med"},{"key":"key-10.3201\/eid2906.230130-202305021908-R15","doi-asserted-by":"publisher","first-page":"856","DOI":"10.1016\/S0140-6736(21)01694-9","article-title":"Safety and immunogenicity of heterologous versus homologous prime-boost schedules with an adenoviral vectored and mRNA COVID-19 vaccine (Com-COV): a single-blind, randomised, non-inferiority trial.","volume":"398","author":"Liu","year":"2021","journal-title":"Lancet"},{"key":"key-10.3201\/eid2906.230130-202305021908-R16","first-page":"46","article-title":"How accurately does the Australian Immunisation Register identify children overdue for vaccine doses? A national cross-sectional study.","volume":"2022","author":"Dalton","year":"2018","journal-title":"Commun Dis Intell"},{"key":"key-10.3201\/eid2906.230130-202305021908-R17","unstructured":"Government of Western Australia. Proof of COVID-19 vaccination to expand state-wide from Monday 31 January [cited 2023 Jan 30]. https:\/\/www.wa.gov.au\/government\/announcements\/proof-of-covid-19-vaccination-expand-state-wide-monday-31-january"}],"container-title":["Emerging Infectious Diseases"],"original-title":[],"link":[{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/6\/23-0130_article","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,30]],"date-time":"2024-11-30T17:59:31Z","timestamp":1732989571000},"score":1,"resource":{"primary":{"URL":"https:\/\/wwwnc.cdc.gov\/eid\/article\/29\/6\/23-0130_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,6]]},"references-count":17,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"URL":"https:\/\/doi.org\/10.3201\/eid2906.230130","relation":{},"ISSN":["1080-6040","1080-6059"],"issn-type":[{"value":"1080-6040","type":"print"},{"value":"1080-6059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6]]}}}